Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Depreciation & Amortization (CF): 2022-2024

Historic Depreciation & Amortization (CF) for Lexeo Therapeutics (LXEO) over the last 3 years, with Dec 2024 value amounting to $304,000.

  • Lexeo Therapeutics' Depreciation & Amortization (CF) rose 32.76% to $77,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $271,000, marking a year-over-year change of. This contributed to the annual value of $304,000 for FY2024, which is 12.18% up from last year.
  • As of FY2024, Lexeo Therapeutics' Depreciation & Amortization (CF) stood at $304,000, which was up 12.18% from $271,000 recorded in FY2023.
  • In the past 5 years, Lexeo Therapeutics' Depreciation & Amortization (CF) ranged from a high of $304,000 in FY2024 and a low of $120,000 during FY2022.
  • For the 3-year period, Lexeo Therapeutics' Depreciation & Amortization (CF) averaged around $231,667, with its median value being $271,000 (2023).
  • Data for Lexeo Therapeutics' Depreciation & Amortization (CF) shows a peak YoY spiked of 125.83% (in 2023) over the last 5 years.
  • Over the past 3 years, Lexeo Therapeutics' Depreciation & Amortization (CF) (Yearly) stood at $120,000 in 2022, then soared by 125.83% to $271,000 in 2023, then climbed by 12.18% to $304,000 in 2024.